Trusted News Discovery Since 2008
{{/content}}
Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient
Video Credit: Geo Beats
Published on June 29, 2020 - Duration: 00:45s
Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient
Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.
You are here
Related news from verified sources
The European health regulator said on Monday it had received an application from U.S. drugmaker Gilead Sciences Inc for approval of its antiviral drug,...
on June 8, 2020 • Reuters India
The U.S. Food and Drug Administration on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in...
on June 15, 2020 • Reuters India
Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead Sciences Inc to manufacture and market antiviral drug...
on June 12, 2020 • Reuters India
Related videos from verified sources
Maker of COVID-19 drug Remdesivir says it will cost about $3,000 per patient 01:47
Video credit: KSWB - Published on June 30, 2020
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment 00:35
Video credit: Wochit Entertainment - Published on June 30, 2020
Coronavirus: Delhi crosses 70,000 Covid-19 cases with 3,788 new patients in 24 hours | Oneindia news 02:42
Video credit: Oneindia - Published on June 24, 2020